At the Life Pharma Detox project, we’re committed to sustainability and public health.

The European Medicines Agency’s updated Guideline on Environmental Risk Assessment (ERA) for Medicinal Products for Human Use (September 2024) underscores the critical importance of evaluating the environmental impact of human medicinal products. This includes protecting aquatic and terrestrial ecosystems from potential hazards of active substances in medications.

The guideline introduces refined testing protocols and risk mitigation measures, ensuring that medicinal products align with ecological safety standards. It highlights the responsibility of pharmaceutical industries to adopt environmentally conscious practices across all stages of product life cycles.

Life Pharmadetox Project, supports these advancements by conducting toxicity tests on treated pharmaceutical residues to assess their impact on the environment and microorganisms. Our findings highlight the system’s potential to reduce pharmaceutical pollution while enabling the reuse of treated water in noncritical applications such as cleaning, irrigation, and heat exchange systems.

Download the Guideline: PDF